Evidence map›Paper›PMID 28576979›Full record

Trial reportJournal of immunology (Baltimore, Md. : 1950)2017

Controlled Human Malaria Infection Leads to Long-Lasting Changes in Innate and Innate-like Lymphocyte Populations.

Maxmillian Mpina, Nicholas J Maurice, Masanao Yajima, Chloe K Slichter, Hannah W Miller, Mukta Dutta, M Juliana McElrath, Kenneth D Stuart, Stephen C De Rosa, John P McNevin and 7 more

Open access · bronzeAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of immunology (Baltimore, Md. : 1950), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
7.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 49 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Advances in Single-Cell Sequencing for Infectious Diseases: Progress and Perspectives.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Vaccines · 2021
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 3 countries.

Maxmillian MpinaClinical Immunology Unit, Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, 4002 Basel, Switzerland.ORCID 0000-0002-9300-6430
Nicholas J MauriceVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109.ORCID 0000-0002-2667-472X
Masanao YajimaVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109.
Chloe K SlichterVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109.
Hannah W MillerVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109.
Mukta DuttaVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109.
M Juliana McElrathVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109.
Kenneth D StuartCenter for Infectious Disease Research, Seattle, WA 98109.
Stephen C De RosaVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109.
John P McNevinVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109.ORCID 0000-0002-9893-9256
Peter S LinsleyBenaroya Research Institute, Seattle, WA 98101.ORCID 0000-0002-8960-4307
Salim AbdullaIfakara Health Institute, Bagamoyo Research and Training Centre, Bagamoyo, Tanzania; and.
Marcel TannerClinical Immunology Unit, Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, 4002 Basel, Switzerland.
Stephen L HoffmanSanaria Inc., Rockville, MD 20850.ORCID 0000-0002-0700-9505
Raphael GottardoVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109.
Claudia A DaubenbergerClinical Immunology Unit, Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, 4002 Basel, Switzerland; Claudia.Daubenberger@unibas.ch mprlic@fhcrc.org.ORCID 0000-0001-7136-0642
Martin PrlicVaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109; Claudia.Daubenberger@unibas.ch mprlic@fhcrc.org.ORCID 0000-0002-0685-9321
Fred Hutch Cancer Center · USSwiss Tropical and Public Health Institute · CHUniversity of Washington · USBoston University · USCenter for Infectious Disease Research · USIfakara Health Institute · TZSanaria · US

Funding

Bioinformatics Approach to Influenza A/H1N1 Vaccine Immune ProfilingU01AI089859 · NIAID · MAYO CLINIC ROCHESTER · PI POLAND, GREGORY A. · 2010 to 2015
$33.8M
Systems Biology CoreU19AI128914 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI KENNETH D STUART · 2017 to 2026
$29.5M
Universal Attenuated Sporozoite Vaccine and Challenge SystemR44AI058375 · NIAID · SANARIA, INC. · PI HOFFMAN, STEPHEN LEV · 2006 to 2018
$9.9M
Diseases of Public Health Importance Training GrantT32AI007509 · NIAID · UNIVERSITY OF WASHINGTON · PI LUND, JENNIFER M · 1997 to 2024
$6.3M
Automating mosquito microdissection for a malaria PfSPZ vaccineR44AI134500 · NIAID · SANARIA, INC. · PI CHAKRAVARTY, SUMANA, HOFFMAN, STEPHEN LEV · 2017 to 2023
$5.9M
Paving the Way for a Novel Therapeutic Approach to Combat HIVDP2DE023321 · NIDCR · FRED HUTCHINSON CANCER RESEARCH CENTER · PI PRLIC, MARTIN · 2012 to 2014
$2.9M
Immune signatures of protection induced by whole parasite malaria vaccinesU19AI089986 · NIAID · SEATTLE BIOMEDICAL RESEARCH INSTITUTE · PI STUART, KENNETH D · 2010 to 2015
$2.3M
FHCRC High-Performance Computing ClusterS10OD020069 · OD · FRED HUTCHINSON CANCER RESEARCH CENTER · PI KOOPERBERG, CHARLES L · 2015 to 2015
$600k
NIAID NIH HHS R44 AI058375NIAID NIH HHS R44 AI134500NIAID NIH HHS T32 AI007509NIAID NIH HHS U01 AI089859NIAID NIH HHS U19 AI089986NIAID NIH HHS U19 AI128914NIDCR NIH HHS DP2 DE023321NIH HHS S10 OD020069
6 · The paper itself

Abstract

Animal model studies highlight the role of innate-like lymphocyte populations in the early inflammatory response and subsequent parasite control following

Indexed as

Immunity, InnateAdultHost-Pathogen InteractionsHumansImmunity, MucosalInterferon-gammaKiller Cells, NaturalLymphocyte SubsetsMalaria, FalciparumMalaria VaccinesMaleMucosal-Associated Invariant T CellsParasitemiaPlasmodium falciparumSporozoitesTanzaniaInterferon-gammaMalaria Vaccines

Identifiers

PMID28576979
PMCPMC5528886
OpenAlexW2620957729

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.